A detailed history of Hrt Financial LP transactions in Sonoma Pharmaceuticals, Inc. stock. As of the latest transaction made, Hrt Financial LP holds 21,519 shares of SNOA stock, worth $90,164. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,519
Holding current value
$90,164
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$0.14 - $0.26 $3,012 - $5,594
21,519 New
21,519 $4,000
Q4 2023

Feb 09, 2024

BUY
$0.14 - $0.77 $3,900 - $21,453
27,862 New
27,862 $5,000

Others Institutions Holding SNOA

About Sonoma Pharmaceuticals, Inc.


  • Ticker SNOA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,100,940
  • Market Cap $13M
  • Description
  • Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally. The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription ...
More about SNOA
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.